Peter Kopelman

Peter Kopelman, CPA, is a Senior Director focusing on Cardiometabolic Health Market Access at Eli Lilly and Company. With extensive experience in Market Access and Patient Affordability strategy, Peter has a proven ability to develop and implement effective strategies in dynamic environments. They hold a Master's degree in Public Accounting from Butler University and are a licensed CPA in Indiana. Prior to their current role, Peter has held various positions at Eli Lilly, including Associate Director of Patient Affordability, and completed internships in audit and financial reporting.